- Home
- EXEL vs ATR Comparison
EXEL vs ATR Comparison
Compare EXEL & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ATR
- Stock Information
- Founded
- EXEL 1994
- ATR 1992
- Country
- EXEL United States
- ATR United States
- Employees
- EXEL 1147
- ATR N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ATR Plastic Products
- Sector
- EXEL Health Care
- ATR Industrials
- Exchange
- EXEL Nasdaq
- ATR Nasdaq
- Market Cap
- EXEL 10.4B
- ATR 10.2B
- IPO Year
- EXEL 2000
- ATR 1993
- Fundamental
- Price
- EXEL $38.31
- ATR $138.69
- Analyst Decision
- EXEL Buy
- ATR Strong Buy
- Analyst Count
- EXEL 21
- ATR 4
- Target Price
- EXEL $43.65
- ATR $175.00
- AVG Volume (30 Days)
- EXEL 4.0M
- ATR 535.2K
- Earning Date
- EXEL 07-28-2025
- ATR 07-31-2025
- Dividend Yield
- EXEL N/A
- ATR 1.30%
- EPS Growth
- EXEL 81.76
- ATR 21.86
- EPS
- EXEL 2.08
- ATR 5.79
- Revenue
- EXEL $2,230,005,000.00
- ATR $3,610,693,000.00
- Revenue This Year
- EXEL $9.88
- ATR $4.41
- Revenue Next Year
- EXEL $12.59
- ATR $5.40
- P/E Ratio
- EXEL $18.45
- ATR $23.96
- Revenue Growth
- EXEL 10.73
- ATR 1.51
- 52 Week Low
- EXEL $25.12
- ATR $130.85
- 52 Week High
- EXEL $49.62
- ATR $178.03
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- ATR 31.05
- Support Level
- EXEL $37.01
- ATR $136.44
- Resistance Level
- EXEL $38.78
- ATR $141.44
- Average True Range (ATR)
- EXEL 1.12
- ATR 3.83
- MACD
- EXEL 0.07
- ATR -0.89
- Stochastic Oscillator
- EXEL 83.79
- ATR 9.72
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.